The Covid Era Tech Promises To Reinvent Cancer Treatment

Benzinga14:11 ET

Merck to Post 3Q Charge of About 28c/Share on Curon Deal >MRK

Dow JonesOct 1 06:46 ET

Express News | Merck & Co Inc - Recording Pre-Tax Charge of $750 Million, or $0.28 per Share

ReutersOct 1 06:45 ET

Express News | Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, Cn201, From Curon Biopharmaceutical

ReutersOct 1 06:45 ET

Merck & Co., Inc. (MRK) Projects 21% Upside With $140 Price Target as Keytruda and New Vaccines Drive Growth

Yahoo FinanceSep 30 04:50 ET

Stocks With the Highest Consensus of Expected ROE Growth, Goldman Sachs Says

Seeking AlphaSep 29 12:28 ET